+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Aspects of Calcium Metabolism in Obstructive Nephropathy

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          In 28 patients with bilaterally recurring calcium – containing renal staghorn calculi, 14 with normal GFR and 14 with mild renal insufficiency, a metabolic investigation of calcium metabolism during intravenous phosphate loading and a morphologic (optical and electron microscopic) study by means of percutaneous bone biopsy were performed. The morphologic investigation showed evidence of osteomalacia in 28.5% of the patients with normal GFR and in 50% of those with renal insufficiency. Moreover, histological evidence of hyperparathyroidism was found in an additional 29% of the patients with renal insufficiency. The metabolic investigation demonstrated low values of Tm PO<sub>4</sub>/GFR only in patients with morphologic evidence of hyperparathyroidism. Moreover, the fall in plasma calcium concentration during phosphate loading appeared to be more evident and significant in patients with osteodystrophy than in those with normal bone. It is possible that the disordered vitamin D metabolism in patients with renal insufficiency and the renal parenchymal lesions observed in all of the patients may have played some role in the pathogenesis of osteomalacia, while the repeated insults to the kidney secondary to ureteropelvic obstructions may have led to early secondary hyperparathyroidism. From the metabolic point of view, our results support the validity of phosphate infusions in assessing the Tm PO<sub>4</sub>/GFR as a functional index of hyperparathyroidism, and the exaggerated fall in plasma calcium concentration as an index of metabolic bone disease.

          Related collections

          Author and article information

          S. Karger AG
          28 November 2008
          : 19
          : 1
          : 32-43
          Divisione di Nefrologia, Istituti Ospitalieri di Verona, Verona; I. Clinica Medica e Clinica Urologica, Università di Padova, Padova, and I. Istituto Anatomia Patologica, Università di Roma, Roma
          180863 Nephron 1977;19:32–43
          © 1977 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 12
          Original Paper


          Comment on this article